Language Settings
My query is:

Combine searches by placing the search numbers in the top search box and pressing the search button.
An example search might look like (#1 or #2) and (#3 or #4)

Loading history...

Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

1. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?

EvidenceUpdates2018

2. The efficacy and safety of anticoagulation in cerebral vein thrombosis: A systematic review and meta-analysis

EvidenceUpdates2018

3. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients

EvidenceUpdates2018

4. Anticoagulation

Trip Latest and Greatest2018

5. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants

EvidenceUpdates2018

6. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis

EvidenceUpdates2018

7. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.

Cochrane2018

8. Anticoagulation for perioperative thromboprophylaxis in people with cancer.

Cochrane2018

9. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.

BMJ2018

10. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications

American Society of Regional Anesthesia and Pain Medicine2018

11. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement

EvidenceUpdates2018

12. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Cochrane2018

13. Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis

EvidenceUpdates2018

14. Anticoagulation for people with cancer and central venous catheters.

Cochrane2018

15. Direct acting oral anticoagulants likely to be better than warfarin for people taking them for atrial fibrillation

NIHR Dissemination Centre2018

16. Screen reminders for GPs did not improve anticoagulant prescribing in atrial fibrillation

NIHR Dissemination Centre2018

17. Extending anticoagulant treatment beyond three months reduces the risk of recurrent blood clots

NIHR Dissemination Centre2018

18. New generation anticoagulants may be safer than warfarin for people with chronic kidney disease

NIHR Dissemination Centre2018

19. An anticoagulant, bivalirudin, may not be safer than the alternative, heparin, when unblocking arteries in the heart

NIHR Dissemination Centre2018

20. Screen reminders for GPs did not improve anticoagulant prescribing in atrial fibrillation

NIHR Dissemination Centre2018